PRANA Biotechnology Ltd
Level 1, 100 Dorcas Street
South Melbourne
Victoria
3205
Tel: 61-3-9690-7892
Fax: 61-3-9690-8587
Website: http://www.pranabio.com/
Email: info@pranabio.com
192 articles about PRANA Biotechnology Ltd
-
PRANA Biotechnology Release: The Lancet Neurology Publishes Prana's Huntington Disease Trial
11/20/2014
-
PRANA Biotechnology Receives FDA Orphan Drug Designation For PBT2 For Huntington Disease
9/5/2014
-
PRANA Biotechnology Alzheimer's Disease Development Program Update
7/18/2014
-
World Leader In Movement Disorders Professor Ira Shoulson Joins PRANA Biotechnology Board
5/14/2014
-
PRANA Biotechnology Tanks As Lead Drug Fails Alzheimer's Study
4/1/2014
-
PRANA Biotechnology Soars As Brain Disorder Drug Succeeds In Phase 2 Trial; Stock Up +39.31% At Market Close (February 18, 2014)
2/19/2014
-
PRANA Biotechnology Provides Update On PBT2 Alzheimer's Disease Extension Trial
12/10/2013
-
PRANA Biotechnology Completes PBT2 Dosing In IMAGINE Alzheimer's Disease Clinical Trial
12/9/2013
-
PRANA Biotechnology's PBT2 Featured As A Top 10 Global Neuroscience Project
11/20/2013
-
PRANA Biotechnology Provides Update On IMAGINE Trial And Extension Trial For Alzheimer's Disease
11/18/2013
-
PRANA Biotechnology's PBT2 Reverses Memory Loss in Normal Aging
10/31/2013
-
PRANA Biotechnology Updates Progress on PBT2 Trials in Alzheimer's and Huntington's Diseases
9/13/2013
-
Parkinson's UK Awards GBP 150,000 to Study PRANA Biotechnology's PBT434
9/4/2013
-
PRANA Biotechnology Prepares for Next Steps in the PBT2 Development Path to Market and Commercialization With Key Appointments Strategy
8/1/2013
-
PRANA Biotechnology Doses First Patient in PBT2 Alzheimer's Extension Study
7/29/2013
-
PRANA Biotechnology Completes Phase 2 Huntington Disease Trial With PBT2
7/23/2013
-
PRANA Biotechnology Release: PBT434 Drug Candidate Shows Potential as "Next-Generation" Disease-Modifying Treatment in Parkinson's Disease
6/20/2013
-
PRANA Biotechnology Presents New Benchmark Test to Assess Huntington's Disease Patients in Clinical Trials
6/19/2013
-
PRANA Biotechnology Announces Share Purchase Plan Closed
5/3/2013
-
PRANA Biotechnology Announces $5.8 Million R&D Refund
4/4/2013